New treatment for lung cancers with a ... - Lung Cancer Support

Lung Cancer Support

4,050 members2,201 posts

New treatment for lung cancers with a BRAF mutation

MFH_Advocate profile image
2 Replies

The FDA has approved a combination of two drugs for the treatment of patients with BRAF V600E mutation-positive metastatic non-small cell lung cancer. This is great news as it adds another targeted therapy to treatment options. fda.gov/drugs/informationon...

Written by
MFH_Advocate profile image
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
2 Replies
JeanE41 profile image
JeanE41

Another treatment to add to the arsenal. We need all the help we can get.

scifiknitter profile image
scifiknitterBlogger

This is indeed great news!

Not what you're looking for?

You may also like...

A new drug for ALK-positive lung cancer approved today

The FDA has approved a new drug for patients with ALK-positive lung cancer. The drug is called...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...

FDA approves another blood test for a mutation (T790M) in lung cancer

Some of you may have heard about new blood tests to check for lung cancer mutations. And you may...

New here and fighting lung and bone cancers

I am new here, and this is my very first post. Back on January 5, 2016 I was given 6-12 months to...

Lung Cancer Treatment

Have been diagnosed with lung cancer again (but now on the right), 6 years later, but this time...